Acis AML/CTF Changes from 1 July 2026
Australia’s AML/CTF regime expands to include certain trust & company services from 1 July 2026, resulting in new compliance obligations for specific products & services for both Acis and our clients. […]
James Creevy, current as of: 24 September 2026.
Nearly a year ago, key provisions of the Pharmacy Business Ownership Act 2024 (Qld) (the Act) commenced, replacing the Pharmacy Business Ownership Act 2001 (Qld) and reshaping the rules around who can own a pharmacy business in Queensland – including how companies and trusts can be structured to hold such interests.
For most existing pharmacy business owners, the transitional period to bring trust deeds and company constitutions into line with the Act by 1 November 2026. With that date now only weeks away, pharmacy owners, and the accountants, lawyers and advisers who act for them, should treat this as a priority to ensure structures are compliant by 1 November 2026.
If your clients’ structures that own or hold an interest in a Qld Pharmacy business haven’t yet been amended, now is the time to act.
The Act clarifies existing ownership requirements and introduces the concept of Material Interest. Under the Act, pharmacy ownership is restricted to:
A person can only hold a Material Interest in a pharmacy business if they are a practising pharmacist, or a close adult relative of one who holds an interest in the business. A Material Interest arises where a person:
The practical impact hasn’t changed since the Act commenced, but the urgency has:
One of the most consequential changes is that corporate shareholders and corporate beneficiaries are no longer permitted. For many existing structures, this means more than a document amendment – it may require a genuine restructure to bring shareholders and beneficiaries into line with the Act.
With the deadline weeks away, it is expected that there will be a large influx of amendment requests so it is important to start the process immediately before time runs out. Structures that haven’t been reviewed may fall out of compliance the moment the transitional period ends, exposing pharmacy owners to potential penalties. Restructuring, where required, also takes time to plan and implement properly, particularly where corporate beneficiaries or shareholders need to be removed and replaced with compliant arrangements.
Acis’s legal team can assist accountants, lawyers and wealth advisors, and their pharmacy clients, with:
If your clients’ structures haven’t been reviewed yet, get in touch with our legal team before the deadline closes.
| Acis does not provide advice in relation to commercial law, taxation, duty, company law or any other matter. We do not purport to provide advice nor should you construe anything in any correspondence with us, or material provided by us, as advice of any kind. |
Australia’s AML/CTF regime expands to include certain trust & company services from 1 July 2026, resulting in new compliance obligations for specific products & services for both Acis and our clients. […]
Missing records, shareholder changes, and director succession issues? Discover practical solutions to common company curveballs. […]
ASIC company registrations can come with hidden compliance gaps. Discover company constitutions, registers and Corporations Act obligations you may be missing. […]